Bio: An experienced product manager in Southwest New Mexico, Rick VanNess is leading an innovative team at TriCore to fully operationalize various products and services to augment TriCore’s current laboratory testing, diversify its business, and position TriCore for value based care. Clinical Analytics, its first commercialized product, uses innovative and copyrighted algorithms to risk stratify populations and produce real-time actionable insights to produce better health outcomes and lowering the total cost of care.
VanNess is also CEO of Mozak, a New Mexico startup focusing on diagnosing and managing mild traumatic brain injury. Previously, he developed and commercialized the first teleretinal screening network as an alternative method for patients to comply with diabetic eye exam needs. VanNess has over ten years of experience in informatics, science, statistics, product development, and medical research.
He holds a Master of Science degree in pharmaceutical sciences from the University of New Mexico and a Bachelor of Science degree in environmental health from New Mexico State University. He was recently honored as one of the Top 40 Individuals under the Age of 40 in New Mexico and is a co-author on a paper discussing Laboratory 2.0 due for publication in the Journal of Laboratory Applied Medicine in November 2018.